Biomedical Technology

Abstract

This PE funds the Military Human Immunodeficiency Virus (HIV) Research Program and the Combatting Antimicrobial Resistant Bacteria (CARB) projects. The goal of the Military HIV Research Program is to refine identification methods for determining genetic diversity of the virus, to conduct preclinical work in laboratory animals including non-human primates to identify candidates for global HIV-1 vaccine, and to evaluate and prepare overseas sites for clinical trials with these vaccine candidates. For the CARB program, funding provides for the development of strategies to prevent, mitigate, and treat antibiotic resistant bacteria in wounds through the CARB - Walter Reed Army Institute of Research (WRAIR) Discovery and Wound Program. In FY21 these programs were transferred from the Defense Health Agency to the United States Army.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2021
Source ID
0602115A_2_2040_PB_2021
Change Summary Explanation
In FY21, funding was transferred to the Army from the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDTE) Program Elements 0602115DHA Projects 246A and 447A.
Service Agency Name
Army

Entities

Organizations

  • United States Army

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Acquired Immune Deficiency Syndrome
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Bacteria
  • Biomedical Technology
  • Clinical Trials
  • Department Of Defense
  • Diseases And Disorders
  • Genetic Variation
  • Health
  • Hiv Infections
  • Infectious Diseases
  • Intellectual Property
  • Laboratory Animals
  • Public Health
  • Test And Evaluation
  • Viruses

Readers

  • Infectious Disease/Epidemiology
  • Military Science and Technology Research and Modernization.

Technology Areas

  • Biotechnology

Related Documents